(Q80196076)

English

Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia

scientific article published on 23 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

stem cell transplantation

1 reference

based on heuristic

inferred from title

aplastic anemia

1 reference

based on heuristic

inferred from title

author name string

George B

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Mathews V

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Viswabandya A

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kavitha ML

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Srivastava A

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Chandy M

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

23 April 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

40

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

13-18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17450183%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705669

0 references

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome after bone marrow transplantation for severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation in the developing world: experience from a center in India

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine-based conditioning for allogeneic stem cell transplantation for multiply transfused patients with Fanconi's anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic stem cell transplantation for patients with severe aplastic anemia following nonmyeloablative conditioning using 200-cGy total body irradiation and fludarabine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705669

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80196076&oldid=2080748723"